ALA 8.33% 13.0¢ arovella therapeutics limited

Unfortunately it looks to be getting tougher. My understanding...

  1. 221 Posts.
    lightbulb Created with Sketch. 119

    Unfortunately it looks to be getting tougher. My understanding isthat under EU MDR Rule 21 Suda’s products will fall into class lll with theassociated consequences.

    MDR Rule 21

    Devices that are composed of substances or of combinations ofsubstances that are intended to be introduced into the human body via a bodyorifice or applied to the skin and that are absorbed by or locally dispersed inthe human body are classified as:

    •class III if they, or their products of metabolism, aresystemically absorbed by the human body in order to achieve the intendedpurpose;

    •class III if they achieve their intended purpose in the stomachor lower gastrointestinal tract and they, or their products of metabolism, aresystemically absorbed by the human body;

    •class IIa if they are applied to the skin or if they are appliedin the nasal or oral cavity as far as the pharynx, and achieve their intendedpurpose on those cavities; and

    classIIb in all other cases.

    https://arcoro.de/en/nasal-sprays-oral-sprays-lozenges-are-you-familiar-with-the-regulatory-amendments-due-to-the-mdr/
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
13.0¢
Change
0.010(8.33%)
Mkt cap ! $136.5M
Open High Low Value Volume
12.5¢ 13.0¢ 12.0¢ $133.5K 1.063M

Buyers (Bids)

No. Vol. Price($)
1 11996 12.5¢
 

Sellers (Offers)

Price($) Vol. No.
13.0¢ 367267 9
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
12.8¢
  Change
0.010 ( 6.25 %)
Open High Low Volume
12.5¢ 13.0¢ 12.5¢ 582454
Last updated 14.53pm 03/05/2024 ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.